Overview

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

Status:
Terminated
Trial end date:
2018-07-30
Target enrollment:
Participant gender:
Summary
This is a perspective, multicenter,single arm, open study to evaluate the efficacy and safety of treatment with CMNa combined with concurrent chemoradiotherapy in patients with locally recurrent squamous cell esophageal carcinoma . Analyses of primary objective (ORR) will be done as defined in the protocol.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong Cancer Hospital and Institute